Novan, Inc.

Home » Novan, Inc.

Secondary

Novan, Inc.

Novan, Inc. is a clinical-stage biotechnology company focused on leveraging nitric oxides natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases.

Symbol

NOVN

Last Closing Price
$4.25

Shares
7,800,000

Effective Date
January 5, 2018

Underwriters
Piper Jaffray

To view the prospectus for Novan, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253